ZK 91296, a partial agonist at benzodiazepine receptors
✍ Scribed by Erling N. Petersen; Leif H. Jensen; Tage Honoré; Claus Braestrup; Wolfgang Kehr; David N. Stephens; Helmuth Wachtel; Dieter Seidelman; Ralph Schmiechen
- Publisher
- Springer
- Year
- 1984
- Tongue
- English
- Weight
- 942 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
✦ Synopsis
ZK 91296 (ethyl 5-benzyloxy-4-methoxymethyl-ficarboline-3-carboxylate) is a potent and selective ligand for benzodiazepine (BZ) receptors. Biochemical investigations indicate that ZK 91296 may be a partial agonist at BZ receptors. Such partial agonism may explain to some extent why ZK 91296 needs higher BZ receptor occupancy than diazepam for the same effect against chemical convulsants and for behavioural effects. The lack of sedative effects, and the very potent inhibition of reflex epilepsy, spontaneous epilepsy and DMCM-induced seizures suggest, furthermore, that ZK 91296 may possess pharmacological selectivity for a particular type of BZ receptor interaction, perhaps including topographic as well as receptor subtype differentiation.
📜 SIMILAR VOLUMES
## Abstract The efficacy of decamethonium as an agonist at the nicotinic acetylcholine receptor has never been determined. Here, we demonstrate how patch clamp recording during rapid perfusion of agonists to outside‐out patches from BC3H‐1 cells can be used to provide an unambiguous estimate of the